spacer
home > ict > autumn 2017 > end point: a costly cause
PUBLICATIONS
International Clinical Trials

End Point: A Costly Cause

Our sister publication, Pharmafile (in its spring 2017 edition), listed the predicted top 50 selling products in the world in 2022. I was astonished to note that the vast majority of these products are biotechnology-based products rather than traditional molecules. Fewer than 10 small molecules feature on this list. In a separate article, Pharmafile discusses the world of $100,000 products and how this will impact on the future of healthcare. If you examine the list of these drugs a little further, you will note that the majority of them are not for rare conditions, but unusual ones. I remember that while working for the agrochemical industry, a development scientist at one of the leading US companies told me that, if the new pesticide did not work on corn or cotton, it would never make economic sense to develop it. In the same group, a farmer who grew courgettes said ‘What hope have I got for the future then?’ The pharmaceutical industry is not yet in this parlous condition, but it may be that the era of the blockbuster is ending and precision medicine will take its place.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

spacer
Dr Graham Hughes
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience

November 16, 2017, Oxford, England and San Francisco, US. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist Bioscience with its SnapFast™ technology platform to provide a broad range of application-specific expression vectors which Twist Bioscience will use to clone synthesized DNA for its diverse customer base.
More info >>

White Papers

By Your Side for a Healthier World

West Pharmaceutical Services, Inc.

Every day, injectable drugs are administered to improve the lives of millions of patients around the world. And every day, West is working by your side to design and manufacture drug packaging and delivery systems that will bring our customers’ drugs from concept to the patient more efficiently, reliably and safely. West understands our customers’ challenges and helps with solutions every step of the way, with cutting-edge production technologies, an unmatched expertise in global regulatory compliance, and an ever-growing knowledge base of pharmaceutical drug product testing, development, packaging and delivery. Whether focused on one piece of the process or an end-to-end solution, West is by your side for a healthier world.
More info >>

 
Industry Events

Biotech Showcase 2018

8-10 January 2018, Hilton San Francisco, Union Square, CA 94102 USA

Biotech Showcase™ is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement